ARX517

Anyone involved in this trial? It's in Michigan, could be a useful option for me.

[Maxone73]

hi, one of the guys on here was, try to search for arx517, I will try as well…very promising drug

[Maxone73]

PapaDugi!!!

Here is my old post, check the comments: healthunlocked.com/advanced...

[Hidden in reply to Maxone73]

Thank you, exactly the data I have been looking for. Now, I'm not the smartest kid in the class so: ARX517 seems a lot like Pluvicto?

[Maxone73 in reply to Hidden]

No it’s a completely different mechanism

onclive.com/view/arx517-dem...

[Maxone73]

ARX517 and Pluvicto target PSMA on prostate cancer cells but work differently. ARX517 is an antibody-drug conjugate that delivers a cytotoxic agent directly to cancer cells. Pluvicto, a radioligand therapy, uses a radioactive molecule attached to a PSMA-targeting ligand, delivering radiation to kill cancer cells. ARX517's mechanism is chemical, through the drug it carries, while Pluvicto's is radiological, utilizing targeted radiation.

[Hidden in reply to Maxone73]

Thanks for this, appreciated

.

[Maxone73]

ah check also AMG 509 and janx007 molecules and the related trials

[God_Loves_Me]

Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of Cancer